Similar Items: Targeting Temozolomide‐Resistant Glioblastoma: Therapeutic Potential of Neuronal Nitric Oxide Synthase Inhibitor
- Potential therapeutic targeting of BKCa channels in glioblastoma treatment
- Temozolomide reconsidered: Real-World evidence in resistant melanoma cases
- Vitamin D should be considered as a targeted therapy in glioblastoma cases
- NR5A2 Promotes Cell Growth and Resistance to Temozolomide Through Regulating Notch Signal Pathway in Glioma [Retraction]
- Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted Therapy
- Robust response to pembrolizumab in temozolomide-associated hypermutated and microsatellite instability-high functional pancreatic neuroendocrine tumor